Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications.

Muranen, Taru A; Greco, Dario; Fagerholm, Rainer; Kilpivaara, Outi; Kämpjärvi, Kati; Aittomäki, Kristiina; Blomqvist, Carl; Heikkilä, Päivi; Borg, Ake; Nevanlinna, Heli

Muranen, Taru A; Greco, Dario; Fagerholm, Rainer; Kilpivaara, Outi; Kämpjärvi, Kati; Aittomäki, Kristiina; Blomqvist, Carl; Heikkilä, Päivi; Borg, Ake; Nevanlinna, Heli.

Affiliation

Muranen TA; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Haartmaninkatu 8, Helsinki, FI-00029, Finland.

Breast Cancer Res ; 13(5): R90, 2011 Sep 20.

Article in En | MEDLINE | ID: mdl-21542898

Subject(s)

Breast Neoplasms/genetics; Mutation; Protein Serine-Threonine Kinases/genetics; Bayes Theorem; Breast Neoplasms/mortality; Calcium-Binding Proteins; Carrier Proteins/genetics; Checkpoint Kinase 2; Chloride Channels/genetics; Chromosomes, Human, Pair 1; Comparative Genomic Hybridization; Female; Gene Dosage; Gene Expression Regulation, Neoplastic; Humans; Low Density Lipoprotein Receptor-Related Protein-1/genetics; Sequence Deletion; Transcription Factors; Wnt Signaling Pathway/genetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Protein Serine-Threonine Kinases / Mutation Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Journal subject: NEOPLASIAS Year: 2011 Type: Article Affiliation country: Finland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google